Alterity Therapeutics announced the appointment of Phillip Hains as the company’s new CFO, effective January 31, 2024. Hains has served as the company secretary of Alterity since 2014, and his experience includes almost 30 years in corporate secretarial, accounting and general management through professional services firm Acclime and predecessor firm The CFO Solution. The appointment of Hains follows the resignation of Kathryn Andrews, who has been CFO since 2014. Andrews has chosen to leave Alterity to pursue other interests and will continue to support the company during the transition.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ATHE:
- Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
- Biotech Alert: Searches spiking for these stocks today
- Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
- Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
- Alterity Therapeutics reports efficacy data for ATH434 in Parkinson’s Disease
